Cargando…
Two SARS-CoV-2 serology assays detect antibodies in the sera of individuals diagnosed with SARS-CoV-2 Omicron variant
Autores principales: | Conklin, Justin, Arroyo, Jennifer, Kumar, Rajnish, Patibandla, Sai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Canadian Society of Clinical Chemists. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868008/ https://www.ncbi.nlm.nih.gov/pubmed/35219651 http://dx.doi.org/10.1016/j.clinbiochem.2022.02.010 |
Ejemplares similares
-
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects
por: Ferrari, Davide, et al.
Publicado: (2021) -
SARS-CoV-2 Multi-Antigen Serology Assay
por: Mazhari, Ramin, et al.
Publicado: (2021) -
Pathogenicity of SARS‐CoV‐2 Omicron
por: Chu, Hin, et al.
Publicado: (2022) -
Renaming the SARS‐CoV‐2 Omicron sublineages as SARS‐CoV‐3 is contrary to nomenclature standards based on evolutionary and serological evidence
por: Qi, Zhongtian, et al.
Publicado: (2022) -
Test performance evaluation of SARS-CoV-2 serological assays
por: Whitman, Jeffrey D., et al.
Publicado: (2020)